Tadalafil once daily: Narrative review of a treatment option for female sexual dysfunctions (FSD) in midlife and older women


Submitted: August 31, 2016
Accepted: December 24, 2016
Published: March 31, 2017
Abstract Views: 4428
PDF: 2238
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

  • Chiara Borghi Department of Morphology, Surgery and Experimental Medicine, Institute of Obstetrics and Gynecology, University of Ferrara, Italy.
  • Lucio Dell'Atti Department of Urology, S. Anna University Hospital, Ferrara, Italy.
Female Sexual Disorders (FSD) include a complex, multidimensional, individual experience that can change as an individual age, suggesting that these problems are caused by multiple factors including psychosocial factors, personal relationships, pathologic changes caused by diseases, and pharmacologic influences. Menopause is an important time for middle aged women and postmenopausal physiological changes could have a significant role in the development of FSD. Few is still known about their correct definition and treatment. Their incidence, prevalence and risk factors are difficult to define because of a high level of overlap in the experience of problems with desire, arousal, and orgasm. Little evidences are known about the best therapeutic approach, and both non-pharmacological and pharmacological treatment options have been described. Among these, phosphodiesterase type 5 inhibitors could be an effective option for many subtypes of female sexual disorders, with an improvement in different aspects of sexual function, such as desire, arousal, orgasm and sexual satisfaction. In this paper authors reviewed what is already known about the use of these vasoactive agents, particularly tadalafil, as a treatment option for female sexual disturbances.

Lucio Dell'Atti, Department of Urology, S. Anna University Hospital, Ferrara
Department of Urology

Supporting Agencies

no

Borghi, C., & Dell’Atti, L. (2017). Tadalafil once daily: Narrative review of a treatment option for female sexual dysfunctions (FSD) in midlife and older women. Archivio Italiano Di Urologia E Andrologia, 89(1), 7–11. https://doi.org/10.4081/aiua.2017.1.7

Downloads

Download data is not yet available.

Citations